Treatment of Campylobacter jejuni Diarrhea
Azithromycin is the preferred first-line treatment for Campylobacter jejuni diarrhea, with a dosing regimen of 1000 mg single dose or 500 mg daily for 3 days, due to its superior efficacy and low resistance rates. 1
First-Line Treatment Options
- Azithromycin should be used as first-line therapy for C. jejuni infections, especially in regions with high fluoroquinolone resistance, with a clinical cure rate of 96% 1
- Early treatment with azithromycin within 72 hours of symptom onset is most effective in reducing symptom duration from 50-93 hours to 16-30 hours 2, 1
- For severe cases or dysentery, azithromycin 1000 mg single dose is recommended 2, 1
- For less severe cases, azithromycin 500 mg daily for 3 days is appropriate 2, 1
Alternative Treatment Options
- Fluoroquinolones (ciprofloxacin, levofloxacin) should only be used in areas with known low fluoroquinolone resistance 1
- Ciprofloxacin dosing: 750 mg single dose or 500 mg twice daily for 3 days 2, 1
- Levofloxacin dosing: 500 mg single dose or 500 mg daily for 3 days 2, 1
- Fluoroquinolone resistance among Campylobacter has increased dramatically worldwide, with resistance rates exceeding 90% in Southeast Asia 1, 3
Treatment Considerations
- Consider local resistance patterns when choosing empiric therapy 1
- Clinical failure occurs in approximately 33% of patients treated with fluoroquinolones when the isolate is resistant 1
- Macrolide (azithromycin, erythromycin) resistance remains relatively low at around 4% for travel-related infections 1
- Rifaximin (200 mg three times daily for 3 days) may be used for non-dysenteric, non-febrile cases, but should not be used with invasive illness 2, 4
Supportive Care
- Maintain adequate hydration with clear liquids, aiming for 8-10 large glasses daily 2
- Dietary modifications include avoiding lactose-containing products, alcohol, and high-osmolar supplements 2
- Consume bland foods such as bananas, rice, applesauce, and toast 2
- Loperamide may be used as adjunctive therapy with antibiotics to further reduce gastrointestinal symptoms and duration of illness 2, 4
- Initial dose of loperamide is 4 mg followed by 2 mg after each loose stool, not to exceed 16 mg in a 24-hour period 2
Special Populations
- Immunocompromised patients should always receive antibiotic treatment, even for mild infections, due to the risk of systemic spread 1
- Elderly patients may be more susceptible to dehydration and should be monitored closely 5
- Children under 2 years should not receive loperamide 2
Common Pitfalls to Avoid
- Using fluoroquinolones empirically without considering local resistance patterns can lead to treatment failure and prolonged illness 1, 6
- Delaying treatment beyond 72 hours can reduce the effectiveness of antibiotics 1
- Continuing use of loperamide alone, or in combination with antibiotics, in the face of worsening symptoms or development of dysentery 2
- Inadequate fluid replacement, particularly in vulnerable populations 5
When to Seek Further Medical Attention
- Presence of blood in stool or severe abdominal pain requires immediate medical attention 5
- Signs of significant dehydration, such as decreased urination, dizziness, or dry mouth 5
- Fever >38.5°C or symptoms persisting beyond 48 hours despite management 5
Most cases of Campylobacter diarrhea are self-limiting, but antibiotics can significantly reduce symptom duration and prevent complications when administered early in the course of illness 1, 7.